copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Vaccine Adverse Event Reporting System (VAERS) Click here for information on reporting to VAERS after COVID-19 vaccination Report an Adverse Event Review reporting requirements and submit reports
Human Papillomavirus (HPV) Vaccine Safety | Vaccine Safety | CDC The Vaccine Adverse Event Reporting System (VAERS) is an early warning system, co-managed by CDC and FDA, that monitors for potential vaccine safety problems Healthcare providers and vaccine manufacturers are required by law to report certain adverse events (any side effect or health problem after vaccination that is concerning to you, even if you are not sure if the vaccine caused the event
Safety profile of human papilloma virus vaccines: an analysis of the US . . . Human papilloma virus (HPV) is the cause of different types of carcinoma Despite the remarkable effectiveness of the HPV vaccines, there have been many complaints about their risk–benefit profile due to adverse events following immunization (AEFI)
Adverse events following 9-valent human papillomavirus vaccine . . . ABSTRACT GARDASIL 9, a 9-valent HPV vaccine approved in 2014, is widely administered for the prevention of HPV-related malignancies Although clinical trials demonstrated a favorable safety profile, rare or delayed-onset adverse events may not be captured pre-licensure Post-marketing surveillance using VAERS offers a complementary approach for signal detection and safety monitoring We
HPV Vaccine is Safe — (Gardasil) | HPV | Vaccines | Vaccine Safety | CDC Understanding HPV Vaccine Safety Studies and Monitoring It is important to understand the following when reading about HPV vaccine safety studies: Anyone can report side effects and adverse events CDC and FDA maintain a vaccine safety monitoring system called the Vaccine Adverse Event Reporting System (VAERS) VAERS accepts reports from anyone, including doctors, patients, and parents While
Spontaneous reports of primary ovarian insufficiency after vaccination . . . Since 2012, reports of primary ovarian insufficiency (POI) temporally associated with receipt of human papillomavirus (HPV) vaccine have been published leading to questions about a potential causal association A Vaccine Safety Datalink study did not find an increased risk for POI after vaccination We reviewed the Vaccine Adverse Event Reporting System (VAERS) to describe POI reports
Parent Concerns About HPV Vaccine Safety Increasing Another CDC-funded vaccine safety program, the Vaccine Safety Datalink (VSD), also performs vaccine safety studies, including those based on reports to VAERS A recent VSD study of the 9-valent HPV vaccine (Gardasil 9), for example, tracked new vaccinations over a 2-year period and identified no new safety issues More Parents Citing Safety
Safety profile of human papilloma virus vaccines: an analysis . . . - PubMed The purpose of this study is to analyse the safety profile of the HPV vaccine basing on real-life data derived from reports of suspected AEFIs collected in the US Vaccine Adverse Events Reporting System (VAERS) and assess if the searches on Google overlap with spontaneous reporting
HPV Vaccine Safety and Effectiveness Data | HPV | CDC Vaccine safety monitoring data With more than 135 million doses of HPV vaccines distributed in the United States, there are robust data showing that HPV vaccines are safe The most common side effects reported through CDC’s Vaccine Adverse Event Reporting System (VAERS) are pain, redness, or swelling in the arm where the vaccine was given, dizziness, syncope (fainting), nausea, and headache